12 completed, 6 unknown, 4 recruiting, 3 terminated. 13 Phase 1, 5 Phase 2, 3 Not applicable, 2 Phase 4, 1 Early Phase 1.
Follow Pharmacokinetics: new trials by email Literature Review of Pharmacokinetics trials Research Report on Pharmacokinetics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer PET imaging with ⁸⁹Zr-trastuzumab, Blood sampling for pharmacokinetics - Lung Cancer (NSCLC), HER2 Expression | Phase 1 | Recruiting | The Netherlands Cancer Institute | 20 | 2026-10-02 | 2026-10-20 |
| Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial Application of an action protocol for the management of delirium through the use of non-pharmacological interventions, Tradicional management of delirium - Delirium Treatment, Delirium Confusional State | Not applicable | Not yet recruiting | Universitat de Lleida | 65 | 2026-04-01 | 2025-05-29 |
| Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients Blood sampling for pharmacokinetics - Solid Cancer, Gastric (Cardia, Body) Cancer | Recruiting | Erasmus Medical Center | 66 | 2025-02-18 | 2025-08-11 | |
| Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety BMND08, Brain electrical activity monitor, Pharmacokinetic Study of Sublingually Administered Psychoactive Substance - Healthy Volunteers | Phase 1 / Phase 2 | Completed | Biomind Labs Inc. | 40 | 2024-10-21 | 2025-03-05 |
| Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance Iohexol, pharmacokinetics - Kidney Function Test | Phase 1 | Unknown | Centre Hospitalier Universitaire de Saint Etienne | 48 | 2024-06-01 | 2024-04-29 |
| A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects Single ascending doses SUL-238, Single dose Placebo, Single dose SUL-238 - Healthy Subjects | Phase 1 | Completed | GEN İlaç ve Sağlık Ürünleri A.Ş. | 83 | 2024-02-19 | 2025-12-01 |
| PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 PET Scan, hu5B1-TCO, 64Cu-Tz-SarAr - Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1 | Withdrawn | Memorial Sloan Kettering Cancer Center | 2023-02-10 | 2026-08-12 | |
| A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant Pharmacokinetics - Lymphoma, Lymphoma, B-Cell | Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 39 | 2022-09-09 | 2026-03-06 |
| Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy Blood samples will be taken for pharmacokinetics and pharmacogenetics - Resistant Arterial Hypertension | Not applicable | Unknown | Ryazan State Medical University | 190 | 2022-03-11 | 2024-04-24 |
| Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 Placebo administration, Confirm SARS-CoV-2 infection, Physical Examination - Corona Virus Infection, Covid19 | Phase 3 | Unknown | MGC Pharmaceuticals d.o.o | 252 | 2021-06-11 | 2022-08-24 |
| NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients. Pharmacokinetics, Dosage of Niraparib - Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer | Phase 4 | Terminated | Hospices Civils de Lyon | 12 | 2021-05-05 | 2025-05-22 |
| Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate pharmacokinetics (PK) measurement - Rheumatic Diseases | Completed | University Hospital, Basel, Switzerland | 28 | 2019-09-26 | 2021-12-01 | |
| Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE) Pharmacokinetics - Critical Illness, Infectious Disease | Unknown | Radboud University Medical Center | 200 | 2017-05-24 | 2020-03-13 | |
| Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia Melatonin, Magnetic Resonance Imaging, Pharmacokinetics - Hypoxic Ischemic Encephalopathy | Early Phase 1 | Recruiting | University of Florida | 70 | 2016-11-09 | 2026-06-29 |
| LifePearl-Doxo Pharmacokinetic (PK) Study Chemoembolization, Pharmacokinetics - HCC, Hepatocellular Carcinoma | Not applicable | Completed | Terumo Europe N.V. | 15 | 2016-04-01 | 2020-01-27 |
| Population Pharmacokinetics of Anti-infectives in Critically Ill Children Pharmacokinetics - Pediatric Intensive Care Unit, Pediatric Immuno-hematology Department | Recruiting | Assistance Publique - Hôpitaux de Paris | 3000 | 2015-09-11 | 2025-11-20 | |
| Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery selinexor, Correlative studies - Recurrent Melanoma | Phase 1 | Completed | Kari Kendra | 8 | 2014-08-22 | 2023-04-04 |
| Intra-monocyte Imiglucerase Kinetics in Gaucher Disease Imiglucérase (drug) pharmacokinetics - Gaucher Disease | Phase 2 | Unknown | University Hospital, Clermont-Ferrand | 60 | 2012-11-01 | 2013-09-27 |
| Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients Pharmacokinetics - Tuberculosis | Completed | University Medical Center Groningen | 20 | 2012-11-01 | 2014-06-23 | |
| Biomarker Development for Response Prediction by DNA Mutational Analysis Biopsy, Blood samples, Pharmacokinetics - Neoplasm Metastasis | Terminated | P.O. Witteveen | 79 | 2011-05-01 | 2018-03-09 |
Showing 20 of 29. Sign in to see all of them.
Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Anxiety Disorders (1) · COVID-19 (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Communicable Diseases (1) · Confusion (1) · Coronavirus Infections (1) · Critical Illness (1) · Delirium (1) · Depression (1) · Dwarfism, Pituitary (1) · Esophageal Neoplasms (1)
Assistance Publique - Hôpitaux de Paris (2) · Memorial Sloan Kettering Cancer Center (2) · Beth Christian (1) · Biomind Labs Inc. (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Erasmus Medical Center (1) · GEN İlaç ve Sağlık Ürünleri A.Ş. (1) · Hospices Civils de Lyon (1) · Kari Kendra (1) · MGC Pharmaceuticals d.o.o (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · P.O. Witteveen (1) · Pfizer (1)
France (6) · United States (6) · Netherlands (4) · Spain (2) · Switzerland (2) · Argentina (1) · Belarus (1) · Belgium (1) · Germany (1) · Greece (1) · Israel (1) · Russia (1) · Thailand (1) · Turkey (Türkiye) (1)
Aida Bonet Auge, Registred Nurse (RN) and PhD (1) · Anchalee Avihingsanon, MD (1) · Angela DM Kashuba, PharmD (1) · Beth Christian, MD (1) · Brigitte C Widemann, M.D. (1) · Gloria Tort Nassarre, Registred Nurse (RN), PhD (1) · JW C Alffenaar, PhD PharmD (1) · Jean-Marc Treluyer, MD, PhD (1) · Jordi Bruix, MD (1) · Kari Kendra (1) · Kristine B Patterson, MD (1) · Laia Fernandez Parra, Registred Nurse (RN) and MSc (1) · Luo Xiaoping, Doctor (1)
PMID 25847298, PMID 28507113, PMID 28507117, PMID 28980166, PMID 29862466, PMID 32988829, PMID 33318012, PMID 34036552, PMID 35292609, PMID 35383374, PMID 36702934, PMID 38167019, PMID 39630067, PMID 40659913, PMID 41036866, PMID 42560139
2019 (1)